Table 3.

Frequency of Maternal Morbidity During the Index ILI Hospitalization by Maternal Antiviral Treatment

Characteristic	Antiviral treatment within 2 days of symptom onset (n = 192)	Antiviral treatment after 2 days of symptom onset (n = 124)	No antiviral treatment (n = 39)	Antiviral treatment (vs. none)		Antiviral treatment within 2 days of symptom onset (vs. none or not within 2 days)
				Unadjusted Odds Ratio (95% CI)	Adjusted Odds Ratio* (95% CI)	Unadjusted Odds Ratio (95% CI)	Adjusted Odds Ratio* (95% CI)
Maternal morbidity composite	13 (6.8)	25 (20.2)	4 (10.3)	1.19 (0.40–3.54) p=0.75	1.21 (0.38–3.85) p=0.75	0.34 (0.17–0.67) p=0.002	0.33 (0.16–0.69) p=0.003
ICU admission	11 (5.7)	20 (16.1)	4 (10.3)
Super-infection with bacterial pneumonia†	2 (1.0)	5 (4.0)	0 (0.0)
Intubation	2 (1.0)	13 (10.5)	2 (5.1)
Bacteremia/sepsis‡	0 (0.0)	5 (4.0)	1 (2.6)

Data are n (%), unless otherwise specified.

^*Adjusted for baseline maternal age, smoking, asthma, anemia, chronic hypertension, diabetes, and medication allergy.

^†Positive x-ray and a positive sputum culture.

^‡Positive blood culture.